Phio Pharmaceuticals (PHIO) Retained Earnings (2016 - 2021)
Historic Retained Earnings for Phio Pharmaceuticals (PHIO) over the last 10 years, with Q3 2021 value amounting to -$113.4 million.
- Phio Pharmaceuticals' Retained Earnings fell 1215.81% to -$113.4 million in Q3 2021 from the same period last year, while for Sep 2021 it was -$113.4 million, marking a year-over-year decrease of 1215.81%. This contributed to the annual value of -$103.6 million for FY2020, which is 927.45% down from last year.
- Per Phio Pharmaceuticals' latest filing, its Retained Earnings stood at -$113.4 million for Q3 2021, which was down 1215.81% from -$109.7 million recorded in Q2 2021.
- Phio Pharmaceuticals' Retained Earnings' 5-year high stood at -$71.6 million during Q1 2017, with a 5-year trough of -$113.4 million in Q3 2021.
- Moreover, its 5-year median value for Retained Earnings was -$90.1 million (2019), whereas its average is -$91.1 million.
- As far as peak fluctuations go, Phio Pharmaceuticals' Retained Earnings plummeted by 2059.96% in 2017, and later plummeted by 891.75% in 2019.
- Quarter analysis of 5 years shows Phio Pharmaceuticals' Retained Earnings stood at -$78.6 million in 2017, then decreased by 9.37% to -$85.9 million in 2018, then decreased by 10.37% to -$94.8 million in 2019, then fell by 9.27% to -$103.6 million in 2020, then dropped by 9.49% to -$113.4 million in 2021.
- Its last three reported values are -$113.4 million in Q3 2021, -$109.7 million for Q2 2021, and -$107.0 million during Q1 2021.